Division of Gastroenterology, Internal Medicine Department, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo National Central General Hospital, Infectious Diseases and Immunology Research Center, Indonesian Medical Education and Research Institute (IMERI), Jakarta, Indonesia.
Division of Tropical Medicine and Infectious Diseases, Internal Medicine Department, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Infectious Diseases and Immunology Research Center, Indonesian Medical Education and Research Institute (IMERI), Jakarta, Indonesia.
BMC Gastroenterol. 2022 Mar 1;22(1):89. doi: 10.1186/s12876-022-02171-7.
Intestinal tuberculosis still has a high incidence, especially in developing countries. The biggest challenge of this disease is the establishment of the diagnosis because the clinical features are not typical. Investigations such as culture, acid-fast bacilli (AFB) staining, and histopathology have low sensitivity, so other investigations are needed. Latest molecular-based diagnostic modalities such as GeneXpert, interferon-gamma (IFN-γ) release assays (IGRA), polymerase chain reaction (PCR), multiplex-PCR, and immunological markers are expected to help diagnose intestinal tuberculosis. This article review will examine the latest diagnostic modalities that can be used as a tool in establishing the diagnosis of intestinal tuberculosis.
Through a literature search, we were able to review the diagnostic values of various available diagnostic modalities as the appropriate additional test in intestinal tuberculosis. Culture as a gold standard has a sensitivity and specificity value of 9.3% and 100% with the MGIT BACTEC system as the most recommended medium. The sensitivity values of AFB staining, histopathology examination, GeneXpert, IGRA, PCR, multiplex-PCR and, immunological markers were ranged between 17.3 and 31%; 68%; 81-95.7%; 74-88%; 21.6-65%; 75.7-93.1%; and 52-87%, respectively. Meanwhile the specificity values were 100%; 77.1%; 91-100%; 74-87%; 93-100%; 96.4-100%; and 70-95%, respectively.
The combination of clinical examination, conventional examination, and the latest molecular-based examination is the best choice for establishing the diagnosis of intestinal tuberculosis. Most recent modalities such as multiplex PCR and immunological marker examinations are diagnostic tools that deserve to be used in diagnosing intestinal tuberculosis as their sensitivity and specificity values are quite high and more evidences are expected to support the application of these examinations shortly soon.
肠结核的发病率仍然很高,特别是在发展中国家。这种疾病最大的挑战是建立诊断,因为临床特征不典型。培养、抗酸杆菌(AFB)染色和组织病理学等检查的敏感性较低,因此需要其他检查。最新的基于分子的诊断方法,如 GeneXpert、干扰素-γ(IFN-γ)释放试验(IGRA)、聚合酶链反应(PCR)、多重 PCR 和免疫标志物,有望有助于诊断肠结核。本文综述将检查可用于建立肠结核诊断的最新诊断方法。
通过文献检索,我们能够回顾各种现有诊断方法的诊断价值,作为肠结核的适当辅助检查。作为金标准的培养具有 9.3%的敏感性和 100%的特异性,MGIT BACTEC 系统是最推荐的培养基。AFB 染色、组织病理学检查、GeneXpert、IGRA、PCR、多重 PCR 和免疫标志物的敏感性值分别为 17.3%至 31%;68%;81-95.7%;74-88%;21.6%至 65%;75.7%至 93.1%和 52%至 87%。同时,特异性值分别为 100%;77.1%;91-100%;74-87%;93-100%;96.4%至 100%和 70%至 95%。
临床检查、常规检查和最新的基于分子的检查相结合是建立肠结核诊断的最佳选择。最新的方法,如多重 PCR 和免疫标志物检查,是诊断工具,值得用于诊断肠结核,因为它们的敏感性和特异性值相当高,并且预计很快就会有更多的证据支持这些检查的应用。